ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer
Harun Öztürk, Harun Cingoz, Turan Tufan, Jiekun Yang, Sara J. Adair, Krishna Seshu Tummala, Cem Kuscu, Meric Kinali, Gamze Cömertpay, Sarbajeet Nagdas, Bernadette J. Goudreau, Husnu Umit Luleyap, Yagmur Bingul, Timothy B. Ware, William L. Hwang, Ku‐Lung Hsu, David F. Kashatus, David T. Ting, Navdeep S. Chandel, Nabeel Bardeesy, Todd W. Bauer, Mazhar Adli
Topics & Concepts
BiologyEpigeneticsPancreatic cancerDNA methylationGene silencingCancer researchChromatinTranscription factorTranscriptomeCell biologyTumor suppressor geneSuppressorRegulation of gene expressionDownregulation and upregulationGene expressionGeneCarcinogenesisCancerGeneticsPancreatic and Hepatic Oncology ResearchPancreatic function and diabetesEpigenetics and DNA Methylation